Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Additional Paid-In Capital

Additional Paid-In Capital at other companies

Lifevantage Corporation logo
Lifevantage CorporationLFVN
$138.73M-0.2%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$613.89M-1.5%
Herbalife logo
HerbalifeHLF
$334M+16.0%
NAG
Niagen Bioscience, Inc. Common StockNAGE
$240.46M+3.6%
BellRing Brands logo
BellRing BrandsBRBR
$52M+37.2%
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
$115.67M+0.7%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's additional paid-in capital?
USANA Health Sciences (USNA) reported additional paid-in capital of $84.73M in Q1 2026.
How has USANA Health Sciences's additional paid-in capital changed year-over-year?
USANA Health Sciences's additional paid-in capital increased by 13.2% year-over-year, from $74.87M to $84.73M.
What is the long-term trend for USANA Health Sciences's additional paid-in capital?
Over 5 years (2020 to 2025), USANA Health Sciences's additional paid-in capital has grown at a 6.0% compound annual growth rate (CAGR), from $62.46M to $83.54M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.